The Patent Finder

Portela & CA., S.A.

Also on record
Records under this name other than the patents Portela & CA., S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Portela & CA., S.A.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,999,100Method for chiral inversion of (S)-(+)-and (R)-(−)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 7,834,177Method for preparation of 10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,288,532Asymmetric catalytic reduction of oxcarbazepine
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,550,759Nitrocatechol derivatives as COMT inhibitors
Formerly held
Term ended
Ended no later than Jul 26, 2026 · USPTO record
Term endedEnded no later than Jul 26, 2026USPTO record
US 7,667,075Sulphonylated Diphenylethylenediamines, Method for Their Preparation and Use in Transfer Hydrogenation Catalysis
Formerly held
Term ended
Term ended Nov 1, 2025 · High confidence
Term endedTerm ended Nov 1, 2025High confidence
US 7,189,846Method for racemization of (S)-(+)- and (R)-(−)-10,11-dihydro-10-hydroxy-5h-dibenz[B,F]azepine-5-carboxamide and optically enriched mixtures thereof
Formerly held
Term ended
Term ended Jun 30, 2025 · USPTO record
Term endedTerm ended Jun 30, 2025USPTO record
US 10,675,287Methods of treatment of partial onset seizures using eslicarbazepine acetate
Formerly held
Term ended
Ended no later than May 6, 2025 · USPTO record
Term endedEnded no later than May 6, 2025USPTO record
US 10,695,354Methods of treatment of partial onset seizures using eslicarbazepine acetate
Term ended
Ended no later than May 6, 2025 · USPTO record
Term endedEnded no later than May 6, 2025USPTO record
US 10,702,536Methods of treatment of partial onset seizures using eslicarbazepine acetate
Term ended
Ended no later than May 6, 2025 · USPTO record
Term endedEnded no later than May 6, 2025USPTO record
US 7,820,813Method for preparation of (S)-(+)- and (R)-(−)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide
Term ended
Term ended Jan 10, 2025 · USPTO record
Term endedTerm ended Jan 10, 2025USPTO record
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited